Enhancing doxorubicin sensitivity in osteosarcoma via iRGD-modified biomimetic nanoparticles targeting MCAM m6A modification.

Saved in:
Bibliographic Details
Title: Enhancing doxorubicin sensitivity in osteosarcoma via iRGD-modified biomimetic nanoparticles targeting MCAM m6A modification.
Authors: Song, Dongjian1,2 (AUTHOR) songdjhenan@foxmail.com, Liu, Qiuliang1 (AUTHOR), Zhang, Da1 (AUTHOR), Yan, Zechen1,2 (AUTHOR), Su, Meng1 (AUTHOR), Zhang, Qian1 (AUTHOR), Zhang, Hui1 (AUTHOR), Shi, Longyan1 (AUTHOR), Fan, Yingzhong1 (AUTHOR), Yang, Heying1 (AUTHOR)
Source: Journal of Translational Medicine. 7/17/2025, Vol. 23 Issue 1, p1-18. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-025-06735-5